Zobrazeno 1 - 3
of 3
pro vyhledávání: '"David Wojciechowski, DO"'
Autor:
Christian P. Larsen, MD, PhD, Flavio Vincenti, MD, Tzuyung D. Kou, PhD, MPH, MA, Craig A. Shadur, MD, Barbara Bresnahan, MD, Stanley C. Jordan, MD, E. Steve Woodle, MD, Nelson Goes, MD, John Vella, MD, David Wojciechowski, DO, Martin S. Polinsky, MD, Andres Gomez-Caminero, PhD, MPH
Publikováno v:
Transplantation Direct, Vol 10, Iss 6, p e1644 (2024)
Background. Belatacept, a selective T-cell costimulation blocker, was associated with improved survival and renal function but also with a risk of posttransplant lymphoproliferative disorder (PTLD) in adult kidney transplant recipients in phase 3 tri
Externí odkaz:
https://doaj.org/article/2074e66814974bf6b1f527406f52b6fd
Autor:
Swee-Ling Levea, MD, Jai G. Prasadh, BS, Benjamin K. Wang, MD, Juan D. Salcedo-Betancourt, MD, Lauren Matevish, MD, Jorge Sanchez Vivaldi, MD, Sarah R. Lieber, MD, MSCR, Jigesh A. Shah, DO, Christine S. Hwang, MD, David Wojciechowski, DO, Parsia A. Vagefi, MD, Madhukar S. Patel, MD, MBA, ScM
Publikováno v:
Transplantation Direct, Vol 10, Iss 6, p e1631 (2024)
Background. Living donation is paramount for expanding the donor pool. The aim of this study was to assess changes over time in self-reported mental health of living donor kidney applicants in efforts to inform patient-centered discussions with poten
Externí odkaz:
https://doaj.org/article/8f49fa894a61468ca43048d390b904ee
Autor:
Christine Hui PharmD, Ryan Kern MD, David Wojciechowski DO, Jasleen Kukreja MD, Jeffrey A. Golden MD, Steven R. Hays MD, Jonathan P. Singer MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 2 (2014)
Belatacept is a novel immunosuppressant that blocks a T-cell costimulation pathway and is approved for use in adult kidney transplant recipients. Its safety and efficacy have not been established after lung transplantation. We present a case of a lun
Externí odkaz:
https://doaj.org/article/180561430b9f449bb73809d1d9ae51af